Gold Nanoparticles for BCR-ABL1 Gene Silencing: Improving Tyrosine Kinase Inhibitor Efficacy in Chronic Myeloid Leukemia
Molecular Therapy - Nucleic Acids - United States
doi 10.1016/j.omtn.2017.05.003
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2017
Authors
Publisher
Elsevier BV